Katalinic Lea, Juric Ivana, Furic Cunko Vesna, Premuzic Vedran, Jelakovic Bojan, Basic-Jukic Nikolina
Department of Nephrology, Arterial Hypertension, Dialysis and Transplantation, University Hospital Centre Zagreb, 10000 Zagreb, Croatia.
J Clin Med. 2024 Sep 19;13(18):5554. doi: 10.3390/jcm13185554.
: Protein-energy wasting (PEW) and sarcopenia are common in chronic hemodialysis (HD) patients, leading to numerous complications and increased mortality. This study aimed to compare the reliability of the SARC-F (Strength, Assistance in walking, Rise from a chair, Climb stairs, and Falls) and the Malnutrition-Inflammation Score (MIS) in assessing sarcopenia and predicting negative outcomes in HD patients. : This cross-sectional study enrolled 109 HD patients. Nutritional assessments were performed, and blood samples were taken for routine blood laboratory investigations. The MIS was used as a scoring system to represent the severity of PEW, while the SARC-F was applied as an indicator of sarcopenia risk and general functional capacity. A multivariable logistic regression was conducted to analyze the association of several predictors with a negative cross-sectional outcome (death). : Patients with SARC-F scores ≥ 4 and MISs ≥ 6 were older, had significantly lower albumin and prealbumin levels, and more severe anemia. They were also more likely to report weight loss and poor appetite. A higher MIS was closely associated with unfavourable nutritional status according to the International Society of Renal Nutrition and Metabolism (ISRNM) criteria for PEW. However, in 71.25% of patients with satisfactory functional capacity (SARC-F scores 0-3), some form of PEW was still observed. After performing logistic regression modelling, only the MIS remained strongly associated with the probability of a negative outcome. : The SARC-F alone often did not correspond to an increased sarcopenia risk or clear clinical and biochemical indicators of PEW in HD patients. When assessing nutritional risk in this group, it is recommended to use more detailed tools, such as the MIS, to ensure the accurate identification of those at the highest risk for negative outcomes.
蛋白质能量消耗(PEW)和肌肉减少症在慢性血液透析(HD)患者中很常见,会导致多种并发症并增加死亡率。本研究旨在比较SARC-F(力量、行走辅助、从椅子上起身、爬楼梯和跌倒)和营养不良-炎症评分(MIS)在评估HD患者肌肉减少症及预测不良结局方面的可靠性。 :这项横断面研究纳入了109例HD患者。进行了营养评估,并采集血样进行常规血液实验室检查。MIS用作代表PEW严重程度的评分系统,而SARC-F用作肌肉减少症风险和总体功能能力的指标。进行多变量逻辑回归分析,以分析几种预测因素与负面横断面结局(死亡)之间的关联。 :SARC-F评分≥4且MIS≥6的患者年龄更大,白蛋白和前白蛋白水平显著更低,贫血更严重。他们也更有可能报告体重减轻和食欲不振。根据国际肾脏营养与代谢学会(ISRNM)的PEW标准,较高的MIS与不良营养状况密切相关。然而,在功能能力良好(SARC-F评分为0-3)的患者中,仍有71.25%观察到某种形式的PEW。进行逻辑回归建模后,只有MIS仍与负面结局的可能性密切相关。 :单独使用SARC-F往往与HD患者肌肉减少症风险增加或PEW明确的临床和生化指标不相符。在评估该组患者的营养风险时,建议使用更详细的工具,如MIS,以确保准确识别出负面结局风险最高的患者。